Patient characteristics by study groups
| Total n=45 | Intervention HIGH HOSP n=15 | Intervention LOW PED n=14 | Control n=16 | |
|---|---|---|---|---|
| Gender: female/male | 40/5 | 13/2 | 13/1 | 14/2 |
| Age, mean (SD) | 50.83 (10.29) | 57.17 (10.51) | 48.49 (8.41) | 46.95 (9.19) |
| Diagnosis | ||||
| Breast/colon | 33/12 | 11/4 | 11/3 | 11/5 |
| Mastectomy/lumpectomy | 17/16 | 6/5 | 7/4 | 4/7 |
| Ostomy | 4 | 1 | 1 | 2 |
| Days since diagnosis, mean (SD) | 77.09 (31.51) | 71.33 (17.61) | 73.64 (33.07) | 85.50 (39.43) |
| Chemotherapy regimen | ||||
| Breast standard adj. | 22 | 8 | 7 | 7 |
| Breast READ protocol | 11 | 3 | 4 | 4 |
| Colon FOLFOX adj. | 12 | 4 | 3 | 5 |
| Chemotherapy cycles before study inclusion: mean (SD) | Br 1.33 (0.48) Co 3.17 (1.64) | Br 1.37 (0.50) Co 2.50 (1.29) | Br 1.45 (0.52) Co 3.33 (1.15) | Br 1.18 (0.40) Co 3.60 (2.19) |
| Chemotherapy cycles applied during interv./control mean (SD) | Br 4.00 (0.00) Co 7.11 (1.45) | Br 4.00 (0.00) Co 7.00 (2.00) | Br 4.00 (0.00) Co 8.00 (0.00) | Br 4.00 (0.00) Co 7.20 (1.10) |
| Educational level | ||||
| Lower | 4 | 2 | 1 | 1 |
| Secondary | 14 | 4 | 5 | 5 |
| Advanced | 26 | 8 | 8 | 10 |
| Missing value | 1 | 1 | ||
| Physical activity prior to diagnosis | ||||
| <150 min moderate activity per week/>150 min week | 13/32 | 4/11 | 6/8 | 3/13 |
| <2×20 min strenuous activity per week/>2×20 min week | 45/0 | 15/0 | 14/0 | 16/0 |
| Weight mean (SD) | 64.86 (23.03) | 62.58 (21.77) | 64.86 (19.32) | 66.99 (27.93) |
| BMI mean (SD) | 24.61 (4.42) | 24.39 (5.27) | 23.80 (2.59) | 25.54 (4.90) |
| Smoking status | ||||
| Never/past* | 19/19 | 5/7 | 8/5 | 6/7 |
| Current | 7 | 3 | 1 | 3 |
| Alcohol intake/week mean (SD) | 4.00 (4.57) | 5.07 (4.92) | 3.15 (3.63) | 3.69 (5.00) |
*Cessation >1 year.
BMI, body mass index; Br, breast; Breast READ protocol, six series of docetaxel plus cyclophosphamide; Breast standard adj., breast standard adjuvant; three series of epirubicin and cyclophosphamide followed by three series of docetaxel; Co, colon; Colon FOLFOX, oxaliplatin and 5-FU (5-fluorouracil) and folinic acid; interv, intervention.
Days since diagnosis refers to the hospital system registered date of diagnosis.